These healthcare winners are still buys: 1Life Healthcare and WELL Health Technologies

Article Excerpt

Both of these firms rewarded our subscribers with spectacular gains as demand for their services during the pandemic accelerated. 1Life (One Medical) has jumped 65.5% since we first recommended the shares at $25 in the March 2020 issue of Power Growth Investor. WELL Health has soared a stellar 437.1% since we first picked its shares in November 2019 at $1.32 a share. We still see both as buys. 1LIFE HEALTHCARE $41.38, is still a buy for aggressive investors. The company (Nasdaq symbol ONEM; TSINetwork Rating: Extra Risk) (www.onemedical.com; Shares o/s: 136.8 million; Market cap: $5.7 billion; No dividends paid) is a membership-based provider of primary health care relying on its One Medical technology platform. It has attracted more than 549,000 members in nine U.S. markets through online services and 77 physical locations. In the three months ended December 31, 2020, revenue jumped by 57.4%, to $121.8 million from $77.4 million a year earlier. One Medical’s membership count is now 549,000, up 30.1% from 422,000, a year ago…